Communications · United States

Innisfree M&A

Deals
6
Latest
Sep 2026
Compare

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deal size
Custom range

6 of 6 deals

Deals Innisfree M&A advised on, most recent first
Advisers
Sep 2026 ACV Auctions –CopartAcquisitionInformation Agent to Copart (acquirer)Announced1,900.0Automotive+1 Evercore (buy-side)Wilson Sonsini Goodrich & Rosati (buy-side)FGS Global (buy-side)J.P. Morgan (sell-side)Davis Polk (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side) Copart acquisition of ACV Auctions
Jul 2026 Forte Biosciences –argenx SEAcquisitionInformation Agent to Avena Merger Sub (acquirer)Announced2,200.0Biotech+1 Goldman Sachs (buy-side)Freshfields (buy-side)Guggenheim Securities (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side) argenx SE acquisition of Forte Biosciences
Jun 2026 Open Lending –ANV Group HoldingsAcquisitionInformation Agent to Lakers Acquisition Sub (acquirer)Completed–Insurtech+1 Paul, Weiss (buy-side)Financial Technology Partners (sell-side)Jones Day (sell-side)Evercore (buy-side) ANV Group Holdings acquisition of Open Lending
Jun 2026 Nuvalent –GSKAcquisitionThe Information Agent to Harmony Row Acquisition Co. (acquirer)Pending10,600.0Biotech+2 Leerink Partners (buy-side)Citi (buy-side)Davis Polk (buy-side)Slaughter and May (buy-side)Centerview Partners (sell-side)Ropes & Gray (sell-side)Jefferies (sell-side)Sidley Austin (sell-side)Sullivan & Cromwell GSK acquisition of Nuvalent
Mar 2026 Day One Biopharmaceuticals –ServierAcquisitionInformation Agent to Servier Pharmaceuticals (acquirer)Pending2,500.0Biotech+2 Goldman Sachs (buy-side)Baker McKenzie (buy-side)Centerview Partners (sell-side)Fenwick & West (sell-side) Servier acquisition of Day One Biopharmaceuticals
Feb 2026 Arcellx –Gilead SciencesAcquisitionThe information agent for the Offer to Gilead Sciences (acquirer)Announced7,800.0Biotech+2 BofA Securities (buy-side)Morgan Stanley (buy-side)Ropes & Gray (buy-side)Centerview Partners (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side) Gilead Sciences acquisition of Arcellx

Activity

Deals by year
Innisfree M&A: deals by year2025: 0, 2026 YTD: 603620252026 YTD: 6 M&A62026 YTDM&AEquity raisings

By announcement date; raisings and IPOs by their own date.

Deals by sector
Innisfree M&A: deals by sectorBiotech4Automotive1Insurtech1

Sector of the business bought or funded.

Deals by size
Innisfree M&A: deals by sizeUS$1bn+5Undisclosed1

Disclosed value in US dollars.

Most often across the table

Firms advising the other side of the same deals.

Offices and contact

Contact

From the firm's own website.

Suggest a correction

A missing deal, a wrong role or an office to add. A link to a public source helps.